Alachua County, Fla., funds by Health and Human Services, Department of
Listing $72,783,143.97 in stimulus funds from Health and Human Services, Department of for Alachua
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| UNIVERSITY OF FLORIDA | $14,682,885 | National Center for Research Resources, Recovery Act Construction Support The state of Florida has the largest proportion (17.8%) of persons age 60 years or older in the nation and this age group represents the fastest growing segment of the population. In the 2000 US Census, more than 3.2 million FlFloridians, or 22.2% of the st... Show more | National Institutes of Health | 1/13/2010 |
| UNIVERSITY OF FLORIDA | $6,113,633 |
Trans-NIH Recovery Act Research Support As life expectancy in the United States continues to rise, the maintenance of physical independence among older Americans has emerged as a major clinical and public health priority. Efficient and reliable locomotion, or the ability to move without assista
This spending item is part of a $29,648,216 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF FLORIDA | $3,996,060 |
Trans-NIH Recovery Act Research Support The proposed work will establish national networking of scientists by providing a new software system (VIVO) and support for scientists using VIVO. Scientists using VIVO will be able to find other scientists and their work. Conversely, scientists using
This spending item is part of a $12,201,380 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF FLORIDA | $1,569,918 |
Trans-NIH Recovery Act Research Support In 2005, Science magazine identified understanding organ regeneration as one of the top 25 unanswered questions in science. For over 400 years scientists have been studying the amazing regenerative capacity of the Axolotl or Mexican Salamander. These amaz
This spending item is part of a $2,078,918 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| EARLY LEARNING COALITION OF ALACHUA COUNTY, INC. | $1,512,558 |
ARRA Child Care and Development Block Grant ARRA Supplemental Funding for the Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care. The Agency will be investing in system
This spending item is part of a $105,331,254 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| SANTA FE COLLEGE | $1,344,059 |
ARRA - Health Information Technology Professionals in Health Care Pitt Community College Region D Consortium - will seek to rapidly create HIT academic programs at Community Colleges or expand existing ones. Community Colleges are G?institutions of higher educationG? as defined by section 101 of the e Higher Education Act... Show more
This spending item is part of a $20,817,547 allocation.
See details
|
Health and Human Services, Department of | 4/02/2010 |
| UNIVERSITY OF FLORIDA | $1,289,516 |
Trans-NIH Recovery Act Research Support The long-range goal of this Program Project is to develop therapeutic strategies that ameliorate muscle atrophy and augment muscle rehabilitation following pathological conditions such as spinal cord injury. Muscle atrophy or loss of muscle mass is a per
This spending item is part of a $2,298,355 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $1,284,837 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement The purpose of this grant is to facilitate the transition of a residency program at the University of Florida College of Dentistry (UFCD) from a traditional one year Advanced Education in General Dentistry (AEGD)D) to a two year AEGD residency program for i... Show more | Health Resources and Services Administration | 8/23/2010 |
| UNIVERSITY OF FLORIDA | $1,209,113 | Trans-NIH Recovery Act Research Support The existing University of Florida Center for Smell and Taste (UFCST) will provide the basis for a Biomedical Research Core Center for Smell and Taste at the University of Florida (Core Center). The existing research infrastructure and environment of the | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $1,000,000 | Trans-NIH Recovery Act Research Support Aim 1. Two inflammatory vascultis syndrome (IVS) mouse models are established. We have detected arterial inflammation and organ involvement with ?¡Ñ68HV infection in interferon gamma receptor KO (IFN?¡ÑR-/-) mice and in human ar | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $1,000,000 | Trans-NIH Recovery Act Research Support Consistent with the ability of herpesviruses to establish persistent and latent infections, about 25% of all herpesvirus genes modulate and/or abrogate host cellular responses to viral infection. Recently, 140 microRNAs have been identified in a-, b-, and | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $981,996 | Trans-NIH Recovery Act Research Support Angiotensin converting enzyme 2 (ACE2) is the key enzyme of the renin-angiotensin system present in endothelial cells. ACE2 produces angiotensin-(1-7) [Ang-(1-7)] which prevents the vasoconstrictive, proliferative, fibrotic and inflammatory effects of Ang | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF FLORIDA | $965,446 | Trans-NIH Recovery Act Research Support Induced pluripotent stem cells (iPSCs) are the most expected cellular sources for regenerative medicine and hold tremendous therapeutic potential. Many groups have shown that adult fibroblasts and epithelial cells can be reprogrammed to a pluripotent, ESC | National Institutes of Health | 9/25/2009 |
| CENTRAL FLORIDA COMMUNITY ACTION AGENCY, INC. | $944,122 |
ARRA - Community Services Block Grant As previously reported under award G0901FLCOS2, the U.S. Department of Health and Human Services (HHS) awarded $29,060,460 to Florida for the Community Services Block Grant Program (CSBG) through the American Recovery and Reinvestment Act (ARRA). These fu
This spending item is part of a $29,060,460 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| UNIVERSITY OF FLORIDA | $926,607 | Trans-NIH Recovery Act Research Support The primary purpose of this research is to develop and evaluate the short-term efficacy of an innovative multiple behavior screening, brief intervention and referral to treatment (MB-SBIRT) model using social and self-image to simultaneously link and redu | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF FLORIDA | $805,869 | Trans-NIH Recovery Act Research Support The public health impact of the HealthStreet approach to recruit more underrepresented populations into research and link them to needed services is significant. When samples enrolled for research studies are comprised of diverse populations, there is gre | National Institutes of Health | 4/26/2012 |
| UNIVERSITY OF FLORIDA | $781,049 | Trans-NIH Recovery Act Research Support Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting over 2.5 million Americans at a cost of over 7 billion dollars per year to Medicare alone. Importantly, 15% of all strokes are attributed to atrial fibrillation with the atrial appe | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF FLORIDA | $758,054 |
Trans-NIH Recovery Act Research Support The goal of this project is to develop a way to observe whether or not new therapies are effective in correcting the disease process in muscles of boys with Duchenne muscular dystrophy (DMD) without the need to take muscle biopsies. We will extend our pas
This spending item is part of a $839,690 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $743,476 |
Trans-NIH Recovery Act Research Support Accidental falls are among the most common reported adverse events which occur during hospitallization. Beginning Oct.1, 2008 the CMS no longer reimburses hospitals for the treatment of injuries resulting from falls which occur during hospitalization. The
This spending item is part of a $1,573,741 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF FLORIDA | $732,500 | Trans-NIH Recovery Act Research Support Tuberculosis is endemic among patients with AIDS and follows an aggressive course with poor localization of mycobacteria into granuloma and widespread infection. Granulomas are monocyte rich collections of cells which derive from the circulating periphera | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF FLORIDA | $732,500 | Trans-NIH Recovery Act Research Support Acute lung infection due to Pseudomonas aeruginosa is a common cause of death in hospitalized patients and the major cause of death in Cystic Fibrosis. A number of virulence factors have been proposed to lead to these poor outcomes. We wish to re-examine | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF FLORIDA | $728,315 | Trans-NIH Recovery Act Research Support The ~2 Mb Prader-Willi/Angelman syndrome (PWS/AS) domain encompasses a group of imprinted genes that are coordinately regulated by a bipartite imprinting center (IC). The PWS-IC functions to establish and maintain the paternal epigenotype across the domai | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF FLORIDA | $725,450 | Trans-NIH Recovery Act Research Support Little is known about the development of abnormal repetitive behavior (e.g., stereotypies, rituals) in children at risk for autism and related neurodevelopmental disorders. This lack of knowledge precludes effective early intervention and prevention stra | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF FLORIDA | $660,000 | Trans-NIH Recovery Act Research Support Hyperoxaluria is considered to be a major risk factor in calcium oxalate stone disease which occurs in about 12% of the American population and, apart from reducing dietary sources of oxalate, there is currently no pharmacological treatment available. Mo | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF FLORIDA | $586,000 | Trans-NIH Recovery Act Research Support We have discovered that the primary causative agent of human dental caries, Streptococcus mutans, undergoes major changes in gene expression and dramatically remodels its surface in response to exposure to oxygen. The goals of this research are to underst | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $535,483 | Trans-NIH Recovery Act Research Support Proteomics is one of emerging tools for drug discovery and medical diagnostics. Two-dimensional gel electrophoresis is one of the most potent methods in proteomics studies. The goal of this project is to develop a lab-on-a-chip device that will improve | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF FLORIDA | $500,000 | Trans-NIH Recovery Act Research Support The University of Florida contributes substantially to the local and regional economy. In 2008, UF created 2,525 jobs and recent studies have shown that UF contributes nearly $6 billion annually to Florida's economy. The university employs about 34,000 pe | National Institutes of Health | 3/18/2010 |
| UNIVERSITY OF FLORIDA | $499,813 | Trans-NIH Recovery Act Research Support Funds to purchase a Leica SP5 laser scanning confocal microscope for communal use. | National Institutes of Health | 4/28/2009 |
| UNIVERSITY OF FLORIDA | $499,813 | Trans-NIH Recovery Act Research Support Funds to purchase a Leica SP5 laser scanning confocal microscope for communal use. | National Institutes of Health | 4/28/2009 |
| UNIVERSITY OF FLORIDA | $499,155 | Trans-NIH Recovery Act Research Support Ionizing radiation (IR) released by detonation can cause the most overwhelming disaster. In acute radiation injury (ARI), the major causes of death are the acute gastrointestinal syndrome (AGS) and BMS (bone marrow syndrome). Pathophysiologically, GI and | National Institutes of Health | 5/10/2010 |
| UNIVERSITY OF FLORIDA | $485,626 |
Trans-NIH Recovery Act Research Support Specifically, the goals of this proposal are 1) to determine whether aging results in uncoupling of eNOS and reduction of bioavailable NO in skeletal muscle resistance arteries, and 2) to determine whether interventional strategies, including aerobic exer
This spending item is part of a $824,838 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF FLORIDA | $452,366 |
Trans-NIH Recovery Act Research Support As life expectancy in the US continues to rise, the maintenance of independence among older Americans has emerged as a major clinical and public health priority. Efficient and reliable locomotion, or the ability to move without assistance, is a fundamenta
This spending item is part of a $1,524,000 allocation.
See details
|
National Institutes of Health | 3/31/2010 |
| UNIVERSITY OF FLORIDA | $448,033 |
Trans-NIH Recovery Act Research Support Our specific aims will determine the best time in the natural history of the disease to treat the patient, identify the ideal EPC population to use for therapy, and determine the best method of delivery to the eye. In this proposal, we are using a combina
This spending item is part of a $996,184 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $437,959 | Trans-NIH Recovery Act Research Support Stroke is the leading cause of disability in the U.S. More than 4.5 million stroke survivors live in the community with functional limitations requiring the assistance of family caregivers. Stroke occurs suddenly, is unpredictable, life-disrupting, and do | National Institutes of Health | 3/15/2010 |
| UNIVERSITY OF FLORIDA | $434,848 |
Trans-NIH Recovery Act Research Support This application addresses Broad Challenge Area (04) Clinical Research, and specific Challenge Topics, 04-NS-103 Developing consortia for clinical research, and is also, in part, relevant to 07-OD(ORDR)-102* Rare disease genetic patient registry. The Univ
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| Mid-Florida Area Agency On Aging, Inc | $434,804 |
Aging Congregate Nutrition Services for States Meal Distribution
This spending item is part of a $4,842,845 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF FLORIDA | $429,719 | Trans-NIH Recovery Act Research Support Cocaine abuse continues to be an important public-health concem. Because cocaine abuse is not an automatic consequence of cocaine use, it is important to study factors that may lead from the latter to the former. Two such factors that have been implicated | National Institutes of Health | 7/16/2009 |
| SUWANNEE RIVER AREA HEALTH EDUCATION CENTER, INC | $414,423 |
The UF AHEC Program will develop and implement a Student/Resident Experiences and Rotations in Community Health (SEARCH) program to provide opportunities for health professions students and residents to serve on multidisciplinary health care teams in unde
This spending item is part of a $600,000 allocation.
See details
|
Health Resources and Services Administration | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $404,480 |
Trans-NIH Recovery Act Research Support In our currently funded project (R01 AG033906), we propose to: 1) characterize ethnic differences in experimental pain sensitivity, endogenous pain inhibition, clinical pain and pain-related disability among older African Americans and non-Hispanic whites
This spending item is part of a $712,744 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF FLORIDA | $402,875 | Trans-NIH Recovery Act Research Support This project is to evaluate the roles of beta cell antigens presented by dendritic cells in the immunotherapy for type 1 diabetes (T1D), T1D mouse model NOD mice are used in the whole project. The objective is to develop optimal approaches for DC-based T1 | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF FLORIDA | $402,875 | Trans-NIH Recovery Act Research Support Sj+?gren's syndrome (SjS) is a systemic autoimmune disease characterized primarily by salivary and lacrimal gland dysfunction. As with many autoimmune connective tissue diseases, there exists a sexual dimorphism in SjS with women affected 10- to 20-times | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF FLORIDA | $402,875 | Trans-NIH Recovery Act Research Support Traumatic brain injury and stroke each affect millions of people yearly; aneurysmal subarachnoid hemorrhage patients suffer from both. Utilizing aneurysmal subarachnoid hemorrhage patients as model for these types of brain injury, it may be possible to id | National Institutes of Health | 5/25/2009 |
| UNIVERSITY OF FLORIDA | $402,875 | Trans-NIH Recovery Act Research Support The aim of the present research is to assess attention capture, sustained attention, and defensive reflex engagement during emotional perception in anxiety patients diagnosed with and without co-morbid major depression, and in healthy control participants | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF FLORIDA | $402,875 | Trans-NIH Recovery Act Research Support Fetal alcohol syndrome (FAS) is a significant cause of mental retardation and birth defects worldwide. However, the mechanisms by which ethanol causes the developmental anomalies and neurotoxicity characteristic of FAS are poorly understood. We hypothesiz | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF FLORIDA | $384,043 | Trans-NIH Recovery Act Research Support The ability of the bacterium Streptococcus mutans to take up DNA from its local environment is known as genetic competence, and it is an important component of the virulence of this organism. Existing data indicates that in the natural biofilm environmen | National Institutes of Health | 4/29/2009 |
| UNIVERSITY OF FLORIDA | $383,257 | Trans-NIH Recovery Act Research Support We can show that gamma-secretase is a potent regulator of vascular permeability and angiogenesis both in vitro and in vivo and that this effect is dependent on the targeted translocation of the C-terminal domain of VEGFR1. Our previous studies have chara | National Institutes of Health | 9/14/2009 |
| UNIVERSITY OF FLORIDA | $378,067 | Trans-NIH Recovery Act Research Support Dichloroacetate (DCA) is an environmentally important xenobiotics, widely distributed in our biosphere. It is also employed as an investigational drug for treatment of congenital forms of lactic acidosis (CLA). The cardinal manifestations of chronic DCA e | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $372,947 | Trans-NIH Recovery Act Research Support The imaging instrumentation requested with the supplemental support was purchased, installed, and calibrated, and is currently being used to acquire data. Data obtianed with the new instrumentaiton to date have been included in a manuscript that is in th | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF FLORIDA | $366,250 | Trans-NIH Recovery Act Research Support The majority of microorganisms in natural and biological ecosystems exist as biofilms, allowing them to better tolerate stresses and fluctuating environmental conditions. Dental plaque is a complex biofilm on the tooth surface that is subject to fluctuati | National Institutes of Health | 4/29/2009 |
| UNIVERSITY OF FLORIDA | $360,153 |
Trans-NIH Recovery Act Research Support This award is for technique development. The technique in this case represents a combination of neuronal manipulations of pairbonding prairie voles, and observations of resulting behavior in semi-natural enclosures. We propose that this combination of met
This spending item is part of a $383,214 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF FLORIDA | $359,579 | Trans-NIH Recovery Act Research Support A central interest in developmental, reproductive, and stem biology is how common precursor cells acquire instruction to differentiate into specialized cell types in various organs. Understanding how cell fates are determined not only satisfies the curios | National Institutes of Health | 9/07/2011 |
| UNIVERSITY OF FLORIDA | $351,740 | Trans-NIH Recovery Act Research Support Prospective Studies of Avian Influenza Transmission in Asia The H5N1 avian influenza epidemic that has ravaged multiple species in Asia, now threatens the United States. National response plans call for aggressive human case identification, antiviral use, | National Institutes of Health | 8/09/2010 |
| UNIVERSITY OF FLORIDA | $334,264 | Trans-NIH Recovery Act Research Support Approximately 50-70% of patients with chronic pain, particularly fibromyalgia sufferers, report sleep difficulties. Because it is not possible to randomly induce chronic pain or chronic insomnia in otherwise healthy participants, the exact nature of the s | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $329,625 | Trans-NIH Recovery Act Research Support Cell death (apoptosis) is implicated in the infectious life cycle of a variety of pathogens, such as the malaria parasite and the West Nile virus, in mosquitoes. Understanding the mechanism of cell death response will help us to develop strategies for co | National Institutes of Health | 8/28/2009 |
| UNIVERSITY OF FLORIDA | $326,049 | Trans-NIH Recovery Act Research Support Title: Establishment of a High performance UPLC-QSTAR Elite Proteomics Platform at University of Florida. This project is to establish an UPLC-QSTAR Elite Proteomics Platform at University of Florida to enhance the mass spectrometry technology infrastruct | National Institutes of Health | 4/28/2009 |
| UNIVERSITY OF FLORIDA | $325,431 | Trans-NIH Recovery Act Research Support Absorption; Acinar Cell; Aciner Cells; Assay; B cell differentiation factor; B cell stimulating factor 2; B-Cell Differentiation Factor-2; B-Cell Stimulatory Factor-2; BCDF; BSF-2; BSF2; BSF2 (B cell stimulating factor 2); Binding Proteins; Bioassay; Biol | National Institutes of Health | 7/12/2010 |
| UNIVERSITY OF FLORIDA | $325,159 |
Trans-NIH Recovery Act Research Support The National Institute on Drug Abuse has funded the Promise Neighborhood Research Consortium (PNRC) to assist the people from high-poverty neighborhoods in America to learn about and understand existing knowledge about prevention and to work together
This spending item is part of a $3,402,213 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| SCHOOL BOARD OF ALACHUA COUNTY | $321,773 | ARRA - Head Start Head Start 2009 ARRA COLA Quality Improvement Funding - The funding was used to establish an extended day enrichment program for preschool children and their families at five locations in Gainesville, Florida. 286 children from 273 families participated t | Administration for Children and Families | 7/09/2009 |
| UNIVERSITY OF FLORIDA | $309,849 |
Trans-NIH Recovery Act Research Support .Abstract G?Metabolomics Network for Drug Response PhenotypeG? Response to Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure G?Grand OpportunitiesG? (RC2), RFAOD- 09-004-Linking Metabolomics to Pharmacogenomics Cardiova
This spending item is part of a $4,507,931 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $308,882 | Trans-NIH Recovery Act Research Support The arteriovenous fistula (AVF) is the preferred mode of vascular access for chronic hemodialysis, because of significantly lower mortality, morbidity, and maintenance costs as compared to other types of access. However, recent reports establish that as m | National Institutes of Health | 9/07/2009 |
| ALCHEM LABORATORIES CORP | $300,000 | Synthesis of known drug candidates as specified in ARRA project 'Cancer Pathway Dissection and Combination Therapies' | National Institutes of Health | 8/25/2010 |
| UNIVERSITY OF FLORIDA | $300,000 | ARRA ? Equipment to Enhance Training for Health Professionals The purpose of this grant proposal is to respond to HRSA-10-258 to secure funding for new equipment for the pre-doctoral program in general dentistry. Equipment requested includes 10 dental simulation workstations and one DentSim simulatioion unit. This equ... Show more | Health Resources and Services Administration | 9/04/2010 |
| UNIVERSITY OF FLORIDA | $298,500 | ARRA ? Equipment to Enhance Training for Health Professionals The purpose of this proposal is to respond to HRSA-10-259 to secure funding for new equipment for four University of Florida College of Dentistry postdoctoral General Dentistry (AEGD) or Pediatric Dentistry (PD) programs including sites inin Gainesville (PD... Show more | Health Resources and Services Administration | 9/01/2010 |
| UNIVERSITY OF FLORIDA | $285,215 |
Trans-NIH Recovery Act Research Support Natural products show outstanding potential as starting point in drug discovery, especially in the quest for anticancer drugs. The research proposed here will explore structure-activity relationships of largazole, a marine natural product that shows nano
This spending item is part of a $641,285 allocation.
See details
|
National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF FLORIDA | $271,026 | Trans-NIH Recovery Act Research Support The long rand goal is to provide intervention to delay or prevent cognitive decline associated with unsuccessful aging, in order to improve the health and well-being of older Americans. The incidence of Alzheimer's disease (AD) is projected to increase d | National Institutes of Health | 9/14/2010 |
| FOUNDATION FOR APPLIED MOLECULAR EVOLUTION, INC. | $266,745 | Trans-NIH Recovery Act Research Support Funds from this administrative supplement are being used in their largest portion to purchase an instrument (a Dr. Oligo) to support the manufacture of DNA molecules that incorporate and constitute reagens for genome sequencing. This instrument has been p | National Institutes of Health | 9/29/2009 |
| FOUNDATION FOR APPLIED MOLECULAR EVOLUTION, INC. | $261,000 | Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): This project, targeted for the National Human Genome Research Institute, will apply nearly a dozen new technologies to improve the performance of DNA chip microarrays as they detect, quantitate, and characterize nuclei | National Institutes of Health | 9/19/2009 |
| UNIVERSITY OF FLORIDA | $260,214 | Trans-NIH Recovery Act Research Support Mycoplasmosis is usually subtle, but Mycoplasma alligatoris causes acute lethal primary infection of susceptible hosts. The goal of this work is to explain the mechanisms and evolutionary origins of that virulence. A genome survey indicated that M. alliga | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF FLORIDA | $250,073 |
Trans-NIH Recovery Act Research Support End stage renal disease (ESRD), one of the most serious and costly complications of systemic lupus erythematosus (SLE), occurs in a sub-set of patients with SLE-related renal involvement. Factors predisposing to ESRD presumably include both genetics and
This spending item is part of a $3,350,000 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF FLORIDA | $240,437 | Trans-NIH Recovery Act Research Support The regulation of actin filament dynamics in neutrophils and macrophages allows cells to crawl to sites of infection and ingest invading pathogens. The present grant focuses on the most abundant actin regulatory protein in macrophages, CapG. Aim 1 will ex | National Institutes of Health | 7/12/2010 |
| UNIVERSITY OF FLORIDA | $240,256 | Trans-NIH Recovery Act Research Support During hematopoiesis, the lineage-specific transcription programs are accompanied and maintained by appropriate patterns of active or repressive histone modifications. Epigenetic mechanisms play an important role in controlling stem cell potency and cell | National Institutes of Health | 8/01/2009 |
| UNIVERSITY OF FLORIDA | $233,860 | Trans-NIH Recovery Act Research Support This is an ARRA Adminisitrative Supplement to an active grant entitled Dynamic Eukaryotic Replication Machines? (R01 GM082849-02). The major goal of the parent grant is to define the mechanism by which the eukaryotic clamp loader, replication factor C (R | National Institutes of Health | 9/09/2009 |
| Mid-Florida Area Agency On Aging, Inc | $233,706 |
Aging Home-Delivered Nutrition Services for States Meal Distribution
This spending item is part of a $2,384,170 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF FLORIDA | $219,750 | Trans-NIH Recovery Act Research Support These R56 bridge funding award is intended to retain two full time employees as well as mouse breeding colonies and critical cell lines generated by this 10 year project during the preparation and resubmission of the competing renewal application. | National Institutes of Health | 1/11/2010 |
| UNIVERSITY OF FLORIDA | $219,747 | Trans-NIH Recovery Act Research Support This revision expands the focus of the OAIC to mitochondrial function and fatigue. Fatigue is a major complaint among older adults and is strongly associated with loss of independence and impairments regardless of underlying medical conditions. Multiple b | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $219,734 | Trans-NIH Recovery Act Research Support This project is collaborative with Dr. Christopher Vulpe , Berkeley University, CA (P42 ES04705: project 2). Both Dr. Vulpe and the Florida team are focused on understanding the molecular mode of action of Superfund chemicals, using different approaches | National Institutes of Health | 9/06/2009 |
| UNIVERSITY OF FLORIDA | $217,844 | Trans-NIH Recovery Act Research Support The bacterium Streptococcus mutans is the primary causative agent of dental caries, which remains the most common chronic disease among children and is untreated in up to 30% of adults over 35 yrs-old. When transiently introduced into the bloodstream foll | National Institutes of Health | 6/01/2009 |
| UNIVERSITY OF FLORIDA | $212,945 | Trans-NIH Recovery Act Research Support We have recently shown that tyrphostin AG490 blocked phosphorylation of Stat5 via the IL-2-JAK-Stat5 signaling pathway in regulatory T-cells in NOD and B6 mice. We have also reported that weaker DNA binding affinity of Stat5B to the DNA in NOD mouse is du | National Institutes of Health | 3/21/2011 |
| UNIVERSITY OF FLORIDA | $210,995 |
Trans-NIH Recovery Act Research Support Insight into post-transcriptional regulatory mechanisms will be sought through the study of a novel paradigm in global regulation, the carbon storage regulatory (Csr) system of Escherichia coli. Csr includes CsrA, an RNA binding protein that regulates tra
This spending item is part of a $394,789 allocation.
See details
|
National Institutes of Health | 7/15/2009 |
| UNIVERSITY OF FLORIDA | $209,220 | Trans-NIH Recovery Act Research Support Numerous factors have contributed to the failure to produce a successful small diameter vascular graft. It is clear that a working graft must include a cellular component since inert materials are unable to interact appropriately with the surrounding tiss | National Institutes of Health | 4/14/2010 |
| UNIVERSITY OF FLORIDA | $204,496 |
Trans-NIH Recovery Act Research Support We will determine whether quantitative genetic interactions from the X contribute to allele specific transcript varaition. By sampling from a set of 3rd chrosomoe introgression lines we will determine whether interactions from an autosomal region contribu
This spending item is part of a $387,696 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF FLORIDA | $200,000 |
Trans-NIH Recovery Act Research Support Dengue viruses (DENV), members of mosquito-borne flaviruses of Flaviviridae family, are included in the NIAID Category A Priority Pathogen as they cause frequent epidemics and serious illness with considerable morbidity and mortality. Two-thirds of human
This spending item is part of a $1,188,851 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $185,577 |
The UF AHEC Program will develop and implement a Student/Resident Experiences and Rotations in Community Health (SEARCH) program to provide opportunities for health professions students and residents to serve on multidisciplinary health care teams in unde
This spending item is part of a $600,000 allocation.
See details
|
Health Resources and Services Administration | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $183,017 | Trans-NIH Recovery Act Research Support Clinical studies have demonstrated that the transfusion of packed red blood cells is independently associated with an increase in infectious complications, as well as mortality. Basic investigation into the cause of this phenomenon is limited and the eff | National Institutes of Health | 9/08/2009 |
| UNIVERSITY OF FLORIDA | $182,725 | Trans-NIH Recovery Act Research Support Porphyromonas gingivalis is the major etiological agent of adult periodontitis. Although well established as a periodontal pathogen, it has more recently been recognized that P. gingivalis may have an important role in systemic disease, including cardiov | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF FLORIDA | $179,338 | Trans-NIH Recovery Act Research Support Endothelial progenitor cell (EPC) dysfunction may have a key role in the pathogenesis of DR. Two populations of EPCs that arise from cultured mononuclear cells (MNC) are the late outgrowth endothelial cells (OECs), which display a clonal phenotype and bel | National Institutes of Health | 1/29/2010 |
| UNIVERSITY OF FLORIDA | $172,874 | Trans-NIH Recovery Act Research Support Higher organisms establish cellular organization by targeting proteins to specific membrane bounded compartments. Most targeting processes involve translocation into or across a membrane bilayer. This is achieved by address signals contained within each p | National Institutes of Health | 9/23/2009 |
| UNIVERSITY OF FLORIDA | $167,787 |
Trans-NIH Recovery Act Research Support We have elucidated the identities and functions of several small molecule signals that control development and mating in the nematode Caenorhabditis elegans. This family of signaling molecules, called ascarosides, is based on the dideoxysugar ascarylose m
This spending item is part of a $349,634 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF FLORIDA | $167,359 | Trans-NIH Recovery Act Research Support The overall objective of the parent proposal (HL081577) has been to investigate the hypothesis that transcription factor Nkx2.5 actively regulates a critical set of genes in postnatal cardiomyocytes to maintain proper cardiac function. Specifically, we ha | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF FLORIDA | $165,089 |
Trans-NIH Recovery Act Research Support Bayesian methods for (incomplete) longitudinal cancer data We continue work from our previous proposal in developing new Bayesian methodology for longitudinal cancer data with missingness. In the presence of missing data that is related to observed or
This spending item is part of a $219,927 allocation.
See details
|
National Institutes of Health | 5/13/2009 |
| UNIVERSITY OF FLORIDA | $156,307 | Trans-NIH Recovery Act Research Support Our goal is to understand the mechanism of Adeno-associated virus (AAV) receptor recognition and internalization. AAV is important both as a simple mammalian T=1 icosahedral virus model and also as a successful vector for human gene therapy that is recei | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF FLORIDA | $149,635 | Trans-NIH Recovery Act Research Support This is a new application in response to RFA-GM-04-002, for which the proposed work should help move toward the long-term goal of selection of antihypertensive drug therapy based on a patient's genetic make-up. Hypertension (HTN) is the most common chroni | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $149,459 |
Trans-NIH Recovery Act Research Support The long term goal is to develop an efficient, safe clinical treatment for diabetic retinopathy using stem cells from the patient's bone marrow or blood that have been activated to repair damaged vessels in the eye. Diabetic retinopathy remains theleading
This spending item is part of a $326,697 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $146,500 | Trans-NIH Recovery Act Research Support Tobacco smoking decreases food intake and weight gain and a high percentage of smokers started smoking to lose weight. Conversely, smoking cessation has been associated with increased food intake and weight gain. Evidence suggests that smoking helps to co | National Institutes of Health | 5/14/2009 |
| UNIVERSITY OF FLORIDA | $146,497 | Trans-NIH Recovery Act Research Support Muscle wasting is a prevalent health care problem that has a high morbidity in the adult population and causes a loss of muscle strength, increased vulnerability to falls, increased health care utilization and a reduced quality of life. In order to develo | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $146,049 | Trans-NIH Recovery Act Research Support Our long-term goal is to elucidate the causes and pathophysiology of osteonecrosis of the jaw (ONJ) in order to create the basis for new effective strategies for prevention and treatment. The objectives of this proposal are to develop an animal model for | National Institutes of Health | 6/08/2009 |
| UNIVERSITY OF FLORIDA | $141,968 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (05) Comparative Effectiveness Research and specific Challenge Topics, 05-AA-101: Innovative Analysis of Existing Clinical Datasets and 05-AA-102: Adaptive Designs and Person-Centered Data Analysis for Alcoh
This spending item is part of a $939,768 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $139,721 | Trans-NIH Recovery Act Research Support This Administrative Supplement is designed to both accelerate the pace and achievement, and broaden the scope, of scientific inquiry into sleep/insomnia in patients with implantable cardioverter defibrillators ??ICD?? through investigation of the cognitiv | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF FLORIDA | $139,618 | Trans-NIH Recovery Act Research Support Postpartum is a specific event that often results in decreased physical activity (PA) for women; thereby placing this special population at increased risk for several chronic diseases and premature mortality. The existing research examining PA during post | National Institutes of Health | 5/05/2009 |
| UNIVERSITY OF FLORIDA | $134,708 | Trans-NIH Recovery Act Research Support We propose the first comprehensive evaluation of the intestinal microbiota in premature infants at risk for necrotizing enterocolitis (NEC). The overall goals respond to objectives of the NIH Funding Opportunity Announcement, which include: 1. gaining a b | National Institutes of Health | 7/27/2010 |
| UNIVERSITY OF FLORIDA | $133,993 |
Trans-NIH Recovery Act Research Support The data obtained to date in the parent grant have shown that A. phagocytophilum strains causing clinical disease in dogs and humans are indistinguishable by current methods. Similarly, horse and squirrel strains appear similar. However, strains infectin
This spending item is part of a $253,916 allocation.
See details
|
National Institutes of Health | 9/09/2009 |
| UNIVERSITY OF FLORIDA | $128,319 |
Trans-NIH Recovery Act Research Support This application addresses Recovery Act Limited Competition: Research and Research Infrastructure 'Grand Opportunities' (GO) (RC2): NIDCR guidelines, RFA-OD-09-004: Area of Scientific Priority 4) Detection of Oral Premalignant and Malignant Lesions. This
This spending item is part of a $770,000 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| NORTH CENTRAL FLORIDA HEALTH PLANNING COUNCIL | $120,000 |
ARRA - Health Information Technology Extension Program This program provides grants for the establishment of Health Information Technology Regional Extension Centers that will offer technical assistance, guidance and information on best practices to support and accelerate health care providers' effororts to bec... Show more
This spending item is part of a $12,184,318 allocation.
See details
|
Health and Human Services, Department of | 4/06/2010 |
| UNIVERSITY OF FLORIDA | $115,129 |
Trans-NIH Recovery Act Research Support Principal Investigator/Program Director (Last, first, middle): Miller, Josef, M. RESEARCH & RELATED Other Project Information 1. * Are Human Subjects Involved? l Yes m No 1.a. If YES to Human Subjects Is the IRB review Pending? l Yes m No IRB Approval Dat
This spending item is part of a $297,519 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $113,146 | Trans-NIH Recovery Act Research Support Mitochondria (mt) play key roles in cellular energy production and cell death. Beta cell function is tightly linked to mitochondria, as both insulin synthesis and glucose stimulated insulin secretion require mitochondrial ATP production. In this context, | National Institutes of Health | 1/20/2010 |
| UNIVERSITY OF FLORIDA | $104,716 | Trans-NIH Recovery Act Research Support Pain is one of the most costly and pervasive public health problems threatening the United States. While ethnic disparities in pain and its treatment have been reported, the influence of ethnicity on responses to analgesics has received scant attention. | National Institutes of Health | 8/15/2009 |
| UNIVERSITY OF FLORIDA | $101,697 |
Trans-NIH Recovery Act Research Support This supplemental award provides support to Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Supplements including: 1) High Risk Acute Lymphoblastic Leukemia (HR-ALL) - Our results establish that we can use comprehensive genom
This spending item is part of a $4,023,579 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF FLORIDA | $101,438 | Trans-NIH Recovery Act Research Support The goal of this project is to understand the molecular mechanisms governing post-initiation events in postreplicative gene transcription during vaccinia virus infection. In recent years it has become increasingly clear that post-initiation events in tran | National Institutes of Health | 4/12/2010 |
| UNIVERSITY OF FLORIDA | $100,000 | Trans-NIH Recovery Act Research Support Agouti-related protein (AGRP) and agouti (ASP) are the only two naturally occurring antagonists of G-protein coupled receptors (GPCRs) identified to date, and when over expressed in mice, result in an obese phenotype. Obesity (body mass index >25) afflict | National Institutes of Health | 12/18/2009 |
| UNIVERSITY OF FLORIDA | $99,999 | Trans-NIH Recovery Act Research Support This is a one-year supplement request for DK065096; Hepatic stem cells: Fusion or Plasticity. The long term goal of the parent grant is to understand the mechanisms by which hepatic oval stem cells are activated into proliferation and migration as well as | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF FLORIDA | $99,987 | Trans-NIH Recovery Act Research Support During the previous funding cycle we identified five monoclonal antibodies (MAbs) against the P1 surface adhesin of Streptococcus mutans that redirect the humoral immune response in mice in terms of quantity, specificity and isotype of elicited antibodies | National Institutes of Health | 3/08/2010 |
| UNIVERSITY OF FLORIDA | $99,471 | Trans-NIH Recovery Act Research Support The long-term goal of this project is to elucidate the molecular determinants of the regulation of corneal epithelial cell phenotype. It is now apparent that corneal epithelial cell phenotype must be held in check by constant transcriptional maintenance, | National Institutes of Health | 1/29/2010 |
| UNIVERSITY OF FLORIDA | $98,331 |
Trans-NIH Recovery Act Research Support Our primary objective is to identify specific gene variants that are related to the formation and rupture of intracranial aneurysms (IA). Our experienced collaborative and highly productive team of Familial Intracranial Aneurysm (FIA) Investigators at 27
This spending item is part of a $8,081,413 allocation.
See details
|
National Institutes of Health | 9/14/2009 |
| UNIVERSITY OF FLORIDA | $95,508 | Trans-NIH Recovery Act Research Support Myotonic dystrophy type 1 (DM1) is caused by a CTG expansion mutation located in the 3' untranslated portion of the dystrophica myotonica protein kinase gene. The identification and characterization of RNAbinding proteins that interact with expanded CUG r | National Institutes of Health | 8/22/2011 |
| UNIVERSITY OF FLORIDA | $93,712 |
Trans-NIH Recovery Act Research Support MECHANISMS OF XENOESTROGEN STRESS: A PROTEOMIC AND FUNCTIONAL GENOMIC APPROACH Xenoestrogens interfere with normal endocrine functioning and have been linked to reproductive and developmental abnormalities in wildlife species and causally associated with
This spending item is part of a $377,960 allocation.
See details
|
National Institutes of Health | 5/19/2009 |
| UNIVERSITY OF FLORIDA | $89,664 | Trans-NIH Recovery Act Research Support The overall purpose of our research project is to understand the consequences of drug resistance mutations on the properties and structure of the HIV-1 protease. This is a major drug target for treatment of HIV-1 infected humans and inhibitors of this enz | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF FLORIDA | $88,085 |
Trans-NIH Recovery Act Research Support Overall Purpose. Loss of mobility characterized by slowing gait speed, exertional fatigue and exhaustion is a hallmark of age-related functional decline. Current studies have not explained the biological reason for this slowing and loss of mobility. In pa
This spending item is part of a $855,594 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $86,136 |
Trans-NIH Recovery Act Research Support Muscle atrophy and weakness secondary to disuse are common clinical phenomena, which can significantly impact activities of daily living and present a major challenge in rehabilitation. Rehabilitation programs designed to maximize strength gains may not b
This spending item is part of a $138,436 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF FLORIDA | $86,063 | Trans-NIH Recovery Act Research Support The overall goal of the experiments performed in this laboratory are to identify the mechanisms controlling the activity of the hypothalamus-pituitary-adrenal (HPA) axis in fetal sheep. Providing a more complete understanding of the activity of the HPA ax | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF FLORIDA | $85,500 | Trans-NIH Recovery Act Research Support The supplemental ARRA funds requested herein will immediately be employed towards achieving the stated goals of Project 3 within this PO1, as well as accelerate the pace of scientific discovery while stimulating the economy. Specifically, we are requestin | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF FLORIDA | $85,500 | Trans-NIH Recovery Act Research Support Shortcourse G-CSF as immunomodulatory therapy for type 1 diabetes: a pilot study | National Institutes of Health | 1/20/2010 |
| UNIVERSITY OF FLORIDA | $84,636 | Trans-NIH Recovery Act Research Support P. gingivalis, a gram negative anaerobe identified as one of the putative oral bacteria associated with severe, chronic forms of periodontal disease, is a successful colonizer of oral tissues, and can invade and remain viable for extended periods in prima | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF FLORIDA | $83,309 |
Trans-NIH Recovery Act Research Support The prevalence of childhood overweight (CO) has tripled in recent decades, and related health care costs have quadrupled. While lifestyle interventions for CO have produced promising short-term results, a substantial percentage of children regain all or m
This spending item is part of a $4,656,242 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| MID-FLORIDA AREA AGENCY ON AGING INC | $82,876 |
ARRA - Communities Putting Prevention to Work: Chronic Disease Self-Manage In collaboration with the Recovery Act-funded Communities Putting Prevention to Work (CPPW) program, this funding will support the deployment of evidence-based chronic disease self-management programs that empower older peoplele with chronic disease to main... Show more
This spending item is part of a $1,000,000 allocation.
See details
|
Administration on Aging | 3/29/2010 |
| UNIVERSITY OF FLORIDA | $82,068 |
Trans-NIH Recovery Act Research Support Porphyromonas gingivalis, a gram-negative anaerobic bacterium, is a recognized periodontopathogen. Although this pathogen mainly inhabits periodontal pockets it also is present in other niches of the oral cavity enroute to the periodontal pockets such as
This spending item is part of a $421,375 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $81,250 | The University of Florida has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of liver cases. These cases are all primary and untreated. The collecti | National Institutes of Health | 9/21/2010 |
| UNIVERSITY OF FLORIDA | $81,088 |
Trans-NIH Recovery Act Research Support This award supports the therapeutic work for childhood Acute Lymphoblastic Leukemia (ALL), which is the most common childhood cancer and is a leading cause of cancer-related death. This project is designed to 1) validate the key TARGET (Therapeutically A
This spending item is part of a $1,708,950 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $75,000 | Trans-NIH Recovery Act Research Support Our long-term goal in grant GM066859 (Bioinorganic Chemistry of Nickel: The Ureases and Nikr) is to understand protein structure, function and dynamics. Furthermore, the proposal is focused on understanding the fundamental aspects of bioinorganic biocatal | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $73,087 | ARRA - Scholarships for Disadvantaged Students Funding for Scholarships for Disadvantaged Students Program. Purpose: Provide scholarship funding for disadvantaged dental and medical students. Goals: recruit, enroll and graduate disadvantage dental and medical students with less debt. Importance ofof ... Show more | Health Resources and Services Administration | 6/14/2010 |
| ATHENA GROUP INC., THE | $72,774 | Trans-NIH Recovery Act Research Support Teacher's iPod (TiP) Administrative Supplement for Summer Funding. This supplement provides summer research experience for high school students, undergraduate students, K-12 teachers, and faculty from non-research intensive institutions to build customiz | National Institutes of Health | 5/21/2010 |
| UNIVERSITY OF FLORIDA | $70,395 |
Trans-NIH Recovery Act Research Support Acute joint injury often results in the development of osteoarthritis. Because osteoarthritis affects 1 in 3 individuals in the United States, there is an urgent need to delineate the biomarker response after acute joint injury so the incipient stages of
This spending item is part of a $424,236 allocation.
See details
|
National Institutes of Health | 3/26/2010 |
| UNIVERSITY OF FLORIDA | $69,095 | Trans-NIH Recovery Act Research Support Liver cirrhosis has an increasing incidence and prevalence in the United States and is closely associated with the development of hepatocellular carcinoma, which has a dismal long-term prognosis. The mechanisms that lead to dysregulated cirrhotic hepatocy | National Institutes of Health | 2/01/2010 |
| UNIVERSITY OF FLORIDA | $68,681 |
Recovery Act Comparative Effectiveness Research - AHRQ The goal of this project is to evaluate the comparative effectiveness of lipid-lowering and antihypertensive medications among HIV-infected individuals. HIV infection itself may impact metabolic abnormalities such as dyslipidemia leading to cardidiovascular... Show more
This spending item is part of a $416,377 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| UNIVERSITY OF FLORIDA | $67,839 | Trans-NIH Recovery Act Research Support Disturbances of iron metabolism increase morbidity and mortality and are among the most common disorders affecting humans. Nearly 20% of women of reproductive age in the US are iron deficient, and iron overload is increasingly being recognized as a public | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF FLORIDA | $67,401 | ARRA - Scholarships for Disadvantaged Students This project funded by the HRSA will be used to make scholarships to students from disadvantaged backgrounds, who have financial need for scholarships and are enrolled as full time students in the College of Medicine or College of Dentistry, or accepted d f... Show more | Health Resources and Services Administration | 9/03/2009 |
| UNIVERSITY OF FLORIDA | $64,503 | Trans-NIH Recovery Act Research Support This Award supports Fellowship Training for Joseph Dzierzewski. A brief description of Mr. Dzierzewski's training program and the research he is conducting as part of this fellowship are provided (both are taken from his NRSA Application). Mr. Dzierzews | National Institutes of Health | 5/21/2009 |
| UNIVERSITY OF FLORIDA | $62,928 | Trans-NIH Recovery Act Research Support The main criterion in assessing the therapeutic efficacy of tissue engineered construct is the successful restoration of the host's physiology. Direct and non-invasive in vivo monitoring of a construct is of great importance for the following reasons: it | National Institutes of Health | 1/08/2010 |
| UNIVERSITY OF FLORIDA | $59,999 |
Trans-NIH Recovery Act Research Support Grant Number: Grant Number: 3R01DE016849-04S1 Project Title: DENTIN STRUCTURE, DEMINERALIZATION AND REMINERALIZATION. The ARRA supplement allowed us to hire additional personnel (post-doc or Research Associate) at UCSF to accelerate work on portions of t
This spending item is part of a $175,718 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF FLORIDA | $59,869 |
Trans-NIH Recovery Act Research Support Tumors arising from non-neural or glial tissue of the brain ('gliomas') constitute one of the most lethal human cancers. Few case-control studies of glioma have been undertaken, and the etiology of the tumor is largely unknown. However, the descriptive ep
This spending item is part of a $833,260 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF FLORIDA | $59,456 |
Trans-NIH Recovery Act Research Support This award supports the therapeutic work for childhood Acute Lymphoblastic Leukemia (ALL), which is the most common childhood cancer and is a leading cause of cancer-related death. This project is designed to 1) validate the key TARGET (Therapeutically A
This spending item is part of a $1,708,950 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $54,191 |
Trans-NIH Recovery Act Research Support In response to the need for treatments appropriate for adolescent smokers in rural Appalachia, this research (utilizing a two-group randomized-control design, n=35 per group) will evaluate the effectiveness and efficacy of a new and innovative Web-based c
This spending item is part of a $729,808 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $54,000 | Trans-NIH Recovery Act Research Support The main objective of the parent grantis to determine the host specific factors that confer susceptibility to urinary tract infection (UTI) complicated by struvite baldder stone foramtion. The parent grant uses a rodent model of UTI caused by the human pa | National Institutes of Health | 12/15/2009 |
| UNIVERSITY OF FLORIDA | $53,765 | Trans-NIH Recovery Act Research Support The objective of this Administrative Supplement is to broaden the translational and applied research activities of Dr. Johannes Vieweg and to support his continued service as a mentor for young investigators involved in patient-oriented research. In this | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF FLORIDA | $52,916 | Trans-NIH Recovery Act Research Support Peptide YY3-36 (PYY3-36) is an important hormone that is released post-prandially into the bloodstream from gut epithelial cells. Its secretion is related to caloric intake, and it induces satiety by acting on Y2 receptors in the brain. Recent research co | National Institutes of Health | 9/23/2010 |
| BANYAN BIOMARKERS INC. | $45,917 | Trans-NIH Recovery Act Research Support To accelerate the production of diagnostic panel for liver injury and validate the utility of the panel with an emphasis on drug-induced hepatoxicity. | National Institutes of Health | 3/10/2010 |
| BANYAN BIOMARKERS INC. | $45,917 | Trans-NIH Recovery Act Research Support TO ACELERATE THE PRODUCTION OF DIAGNOSTIC PANEL FOR LIVER INJURY AND VALIDATE THE UTILITY OF THE PANEL WITH AN EMPHASIS ON DRUG-INDUCED HEPATOTOXICITY. | National Institutes of Health | 3/10/2010 |
| UNIVERSITY OF FLORIDA | $45,762 | Trans-NIH Recovery Act Research Support The high rate of unintended pregnancy can be attributed to inadequate access to or use of contraceptives, or both. It is important to provide alternative choices for effective contraception to meet the needs of people with different ethnic, cultural, and | National Institutes of Health | 7/01/2010 |
| UNIVERSITY OF FLORIDA | $45,150 | Trans-NIH Recovery Act Research Support Maternal cortisol concentrations are normally increased by 2-3 fold in pregnancy. Maternal cortisol levels appear to affect fetal skeletal and visceral growth. Our previous data show reduced growth in fetuses of ewes with either increased or decreased mat | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $45,150 | Trans-NIH Recovery Act Research Support Maternal cortisol concentrations are normally increased by 2-3 fold in pregnancy. Maternal cortisol levels appear to affect fetal skeletal and visceral growth. Our previous data show reduced growth in fetuses of ewes with either increased or decreased mat | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF FLORIDA | $44,732 | Trans-NIH Recovery Act Research Support Dichloroacetate (DCA) is an environmentally important xenobiotic, widely distributed in our biosphere. It is also employed as an investigational drug for treating genetic mitochondrial (mt) diseases and cancer. ES07355 is focused on pin-pointing the mo | National Institutes of Health | 6/17/2009 |
| UNIVERSITY OF FLORIDA | $42,152 | Trans-NIH Recovery Act Research Support The goal of this proposal is to enhance naturally occurring processes that can lead to partial improvement of phrenic motoneuron (PhMN) functions that were initially lost or modified after high cervical spinal cord injury (SCI) andto define underlying cha | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $36,625 | Trans-NIH Recovery Act Research Support This work proposes to expose medical students to abnormal clinical conditions through the use of immersive virtual patients (VPs). Immersive VPs are highly interactive, computer-generated, life-size virtual 3D characters. As medical educators have diffi | National Institutes of Health | 9/03/2009 |
| UNIVERSITY OF FLORIDA | $35,475 | Trans-NIH Recovery Act Research Support Prior research indicates pervasive racial/ethnic disparities in quality of care among nursing home residents. This study proposes to examine how nursing home residents' race, nursing home segregation and residential segregation influence quality of care i | National Institutes of Health | 9/19/2009 |
| UNIVERSITY OF FLORIDA | $35,000 |
Trans-NIH Recovery Act Research Support Emerging imaging technologies are an important component of efforts to effectively detect and treat cancer. The American Recovery and Reinvestment Act of 2009 specifically targets the development of comparative effectiveness research (CER) to increase the
This spending item is part of a $3,962,575 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF FLORIDA | $34,854 |
Trans-NIH Recovery Act Research Support The goal of this project is to use contemporary genomic profiling approaches to identify genetic alterations contributing to the pathogenesis and treatment outcome of high risk acute leukemia. Despite best current therapy, acute lymphoblastic leukemia rem
This spending item is part of a $1,573,220 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF FLORIDA | $32,963 |
Trans-NIH Recovery Act Research Support This two-year study will utilize a randomized design with the active interventions running for 18 months. We have 26 active US sites (27 approved sites with one having to drop out due to lack of indirect cost recovery to pay IRB costs). The 26 sites will
This spending item is part of a $1,349,862 allocation.
See details
|
National Institutes of Health | 8/19/2009 |
| UNIVERSITY OF FLORIDA | $32,230 | Trans-NIH Recovery Act Research Support Hyperoxaluria is considered a major risk factor in the genesis of calcium oxalate stone disease which occurs in about 12% of the U. S. population costing an estimated $2 billion annually. Oxalate homeostasis is governed by the amount of dietary oxalate ab | National Institutes of Health | 4/09/2010 |
| BANYAN BIOMARKERS INC. | $30,351 | Trans-NIH Recovery Act Research Support The overall objective of the current Summer Student Research Experiences Administrative Supplements to Svetlov-SBIR grant (5R44DK074205-03) is to develop experimental data on systemic and topical use of ASS to clear the body of bacterial toxins and accele | National Institutes of Health | 7/19/2009 |
| UNIVERSITY OF FLORIDA | $27,074 |
The Systolic Blood pressure Intervention Trial, (SPRINT) contractor will conduct a multicenter, randomized clinical trial to determine whether treating systolic blood pressure to a lower goal than currently recommended, will reduce cardiovascular disease.
This spending item is part of a $2,491,798 allocation.
See details
|
National Institutes of Health | 9/24/2010 |
| UNIVERSITY OF FLORIDA | $21,383 | Trans-NIH Recovery Act Research Support See comment.This project uses recombinant adeno-associated viral vectors to deliver genes encoding constructs to knock-down huntingtin in striatal neurons. Long-term knock-down of striatal huntingtin will test the hypothesis that reduced huntingtin expres | National Institutes of Health | 7/20/2009 |
| UNIVERSITY OF FLORIDA | $21,179 |
Recovery Act Comparative Effectiveness Research - AHRQ The Scalable PArtnering Network for CER: Across Lifespan, Conditions, and Settings, or SPAN, will develop a distributed research network that is interoperable across a range of health care systems and sites, incorporating large and diverse patienent populat... Show more
This spending item is part of a $8,272,272 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| ALCHEM LABORATORIES CORP | $21,000 | Synthesis of 10-15 g of NSC D740482-G (CAS 918504-65-1) | National Institutes of Health | 4/21/2010 |
| UNIVERSITY OF FLORIDA | $20,000 |
Trans-NIH Recovery Act Research Support We have updated the Queuosine (Q) subsystem in the SEED database and analyzed 727 genomes for the presence of tgt, the signature gene of the Q pathway encoding tRNA guanine transglycosylase (TGT), and the precursor biosynthesis genes (queCDEF) [3]. As sho
This spending item is part of a $75,000 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF FLORIDA | $19,100 |
Trans-NIH Recovery Act Research Support A detailed understanding of the important interaction between hemodynamics and vascular remodeling has been limited by the non-linear relationships between these elements that regulate this process. To this end, we have initiated a systems-based analysis
This spending item is part of a $176,425 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF FLORIDA | $16,994 | Trans-NIH Recovery Act Research Support This grant provided summer research experiences for 2 college students in health-related scientific research | National Institutes of Health | 6/08/2009 |
| UNIVERSITY OF FLORIDA | $15,341 | Trans-NIH Recovery Act Research Support The Pharmacoxtoxicology of Treichloroethylene Metabolites Study Specific Aims: For several years we have researched the kinetics, metabolism and human toxicology of dichloroacetate | National Institutes of Health | 6/17/2009 |
| FOUNDATION FOR APPLIED MOLECULAR EVOLUTION, INC. | $15,000 | Trans-NIH Recovery Act Research Support This supplement was requested to purchase a digital gel documentation system in order to screen hundreds of target compounds for their ability to modulate the activity of the membrane progesterone receptors | National Institutes of Health | 7/15/2010 |
| UNIVERSITY OF FLORIDA | $10,869 | Trans-NIH Recovery Act Research Support The requested supplement added to the scientific agenda of the parent project (k23 White Matter and Cognition in PD), and provided summer employment for 2 undergraduate research trainees, as well as supplemental funds for a graduate student to act as over | National Institutes of Health | 7/20/2009 |
| UNIVERSITY OF FLORIDA | $10,460 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| UNIVERSITY OF FLORIDA | $8,538 | Trans-NIH Recovery Act Research Support This award is for a summer student supplement. I recruited one undergraduate student this summer, Michael H. Rosenberg, who is working on the specific aims outlined in the proposal. The purpose of this award is to provide training in molecular genetics | National Institutes of Health | 7/13/2009 |
| UNIVERSITY OF FLORIDA | $4,490 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| UNIVERSITY OF FLORIDA | $0 |
Trans-NIH Recovery Act Research Support This proposal expands the research scope of the parent grant (R01 AG033906) by investigating biological markers reflecting predisposing factors for and the stress-related consequences of chronic pain. Consistent with the OppNet priorities, this proposal t
This spending item is part of a $219,658 allocation.
See details
|
National Institutes of Health | 9/01/2010 |